Camber Capital Management LP Bristol Myers Squibb CO Call Options Transaction History

Camber Capital Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $119 Million - $133 Million	-2,000,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $57.7 Million - $65.4 Million	1,000,000 Added 100.0%	2,000,000 $124 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $48.8 Million - $63.2 Million	1,000,000 New	1,000,000 $52 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $110 Million - $125 Million	-2,000,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $101 Million - $126 Million	2,000,000 New	2,000,000 $111 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.